Inhibition and induction of CYP enzymes in humans: an update

J Hakkola, J Hukkanen, M Turpeinen, O Pelkonen - Archives of Toxicology, 2020 - Springer
The cytochrome P450 (CYP) enzyme family is the most important enzyme system catalyzing
the phase 1 metabolism of pharmaceuticals and other xenobiotics such as herbal remedies …

Resveratrol and its human metabolites—effects on metabolic health and obesity

M Springer, S Moco - Nutrients, 2019 - mdpi.com
Resveratrol is one of the most widely studied polyphenols and it has been assigned a
plethora of metabolic effects with potential health benefits. Given its low bioavailability and …

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

M Martignoni, GMM Groothuis… - Expert opinion on drug …, 2006 - Taylor & Francis
Animal models are commonly used in the preclinical development of new drugs to predict
the metabolic behaviour of new compounds in humans. It is, however, important to realise …

Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs

G Milano, F Innocenti, H Minami - Cancer Science, 2022 - Wiley Online Library
Irinotecan is a topoisomerase inhibitor, widely used in treatment of malignancies including
pancreatic ductal adenocarcinoma (PDAC) as part of the FOLFIRINOX regimen prescribed …

Caffeine consumption through coffee: Content in the beverage, metabolism, health benefits and risks

J dePaula, A Farah - Beverages, 2019 - mdpi.com
Caffeine (1, 3, 7-trimethylxanthine) is the most consumed psychoactive substance in the
world, acting by means of antagonism to adenosine receptors, mainly A1 and A2A. Coffee is …

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

CE Staatz, SE Tett - Clinical pharmacokinetics, 2004 - Springer
The aim of this review is to analyse critically the recent literature on the clinical
pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplant recipients …

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

D Wang, Y Guo, SA Wrighton, GE Cooke… - The pharmacogenomics …, 2011 - nature.com
Abstract Cytochrome P450 3A4 (CYP3A4) metabolizes∼ 50% of all clinically used drugs.
Although CYP3A4 expression varies widely between individuals, the contribution of genetic …

Mechanisms of drug resistance in cancer chemotherapy

YA Luqmani - Medical principles and practice, 2005 - karger.com
The management of cancer involves procedures, which include surgery, radiotherapy and
chemotherapy. Development of chemoresistance is a persistent problem during the …

Resveratrol'biotechnological applications: Enlightening its antimicrobial and antioxidant properties

J Sharifi-Rad, C Quispe, A Durazzo, M Lucarini… - Journal of Herbal …, 2022 - Elsevier
Abstract Introduction Resveratrol (3, 5, 4'-trihydroxy-trans-stilbene) is a polyphenol obtained
from diverse groups of plants, especially in the muscadine grape, red wine, lingonberry …

Maraviroc: a review of its use in HIV infection and beyond

SM Woollard, GD Kanmogne - Drug design, development and …, 2015 - Taylor & Francis
The human immunodeficiency virus-1 (HIV-1) enters target cells by binding its envelope
glycoprotein gp120 to the CD4 receptor and/or coreceptors such as CC chemokine receptor …